Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 1.65M but it saw 1110163 shares traded in last market. With a market cap of 171.62M USD, the company’s current market price of $26.67 came falling about -7.27 while comparing to the previous closing price of $28.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $1146.01 and as low as $6.76. In the recent trading on the day, stock has struck highest price mark of $24.35 while lowest mark touched by it was $28.9449.
Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $17.05, while its current price level is -97.67% below from 52-week high level whereas it is 294.53% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $19.08 while that of 200 days or SMA-200 reads an average of $34.24. A closer look into the stock’s movement over the week reveals that its volatility is standing at 24.87% during that period while stretching the period over a month that decreases to 21.61%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 63.35 which implies that the stock is in neutral territory.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving 46.62% up while it is 216.37% when we observe its performance for the past one month. Year-to-date it is -19.13% down and over the past year, the stock is showing a downside performance of -97.46%.
The company is expected to be releasing its next quarterly report on 2025-Mar-17, for which analysts forecasted an EPS of -3.09 while estimate for next year EPS is -11.89. In next quarter, company is expected to be making quarterly sales of $2.8M as analysts are expecting the sales for current fiscal year at $11.1M and seeing the company making $98.8M in sales next year. Moreover, analysts are in estimates of $2.6M for current-quarter revenue.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 6.43M with 0.00% of that held by the insiders while 2.72% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -89.94% and return on equity (ROE) at -106.12%. Stock’s beta reads 1.15. Stock has a price to book (P/B) ratio of 0.84 while price to sale or P/S ratio amounts to 17.01. Its return on asset (ROA) is -81.95% on average.
